A genomic test for the human papillomavirus has shown promise in early-stage trials, raising hopes that it could bolster cervical cancer screening among women living in sub-Saharan Africa, the region ...

The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...

In a clinical study designed to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer, HPV status determined by the RNAscope HPV test was highly predictive ...

Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, ...

HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "HPV Testing and Pap Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's ...

Cervical cancer is one of the most preventable cancers, yet screening is often delayed. Doctors explain why every woman over ...

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

EARLY detection through proper screening is key to eliminating cervical cancer, but awareness and access remain major hurdles in Malaysia. One challenge is the slow adoption of human papillomaviruses ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...